Skip to main content
Clinical Trials/IRCT20220928056051N2
IRCT20220928056051N2
Not yet recruiting
Phase 3

Assessment of the N-Acetyl cysteine effect on therapeutic outcome of diabetic foot ulcers

Oroumia University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Oroumia University of Medical Sciences
Enrollment
50
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age above 18 years
  • Grade 3 or 4 diabetic foot ulcer according to Wagner criteria

Exclusion Criteria

  • Allergy to N\-Acetyl cysteine and sulfur products
  • Pregnancy and breastfeeding
  • Other causes of ulcers except diabetes include trauma and others
  • A generated\- ulcers skin disease
  • Impossibility of taking tablets orally
  • Patients treated with chemotherapy or radiotherapy drugs
  • Taking drugs such as: corticosteroids at a minimum dose equivalent to 40 milligrams of prednisolone, mycophenolate, cyclosporine, tacrolimus, rituximab
  • Hospitalized for a diabetic foot ulcer in the last month and receiving injection antibiotic treatment
  • Stenosis and severe cramping of the lower limbs vessels based on vascular sonography
  • Chronic alcohol consumption of more than 250 cc daily

Outcomes

Primary Outcomes

Not specified

Similar Trials